There's a short answer to whether CRISPR Therapeutics (NASDAQ: CRSP) could help you become a millionaire: Yes. However, that response makes little sense unless you understand why the company's prospects are so strong.

Here are five reasons why the company, which just went public in 2016, could make you a millionaire.

CRISPR and Vertex Pharmaceuticals say they expect to complete their biologics license application early next year for exa-cel, to treat blood disorders beta-thalassemia and severe sickle cell disease. The talk is the one-dose therapy, which has so far been curative in trials, would cost $2 million per dose. While that potential price tag has engendered no small bit of controversy, even one far lower would certainly help fund continuing operations for CRISPR, which would get a 40% share of profits from the treatment.

Continue reading

Source Fool.com